ANN VASH: Open Payments
NPI 1154553196 · LINTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 57 payments from 17 companies in 2025. Trend: 2023 $231 · 2024 $852 · 2025 $1,031
Food & beverage: $1,031
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $207 |
| Novo Nordisk Inc | 9 | $153 |
| Vanda Pharmaceuticals Inc. | 6 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $96 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| Collegium Pharmaceutical, Inc. | 4 | $72 |
| Aimmune Therapeutics, Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Amgen Inc. | 2 | $29 |
Products named: VRAYLAR, FANAPT, CAPLYTA, Auvelity, Jornay PM, Rybelsus, Wegovy, ZENPEP.
Industry payments across IN — which companies pay providers there.
